MHC-linked type 1 diabetes genes in NOD mice
MHC-linked type 1 diabetes genes in NOD mice
批准号:
22500399
负责人:
HATTORI Masakazu
金额:
$2.75万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2012
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Type 1 diabetes is a polygenic autoimmune disease in man and the NOD mouse. The genes in the MHC region are the most important in determining susceptibility or resistance to type 1 diabetes. Replacement of (homologous recombination) of the NOD MHC class IK region with the R209 MHC class IK region prevented the development of diabetes and insulitis in the intra-MHC recombinant NOD mice. Similarly the replacement of the region of the NOD A, E and D with that of the R209 prevented the development of diabetes and insulitis. We have established six congenic lines with a homozygous segment of r209/r209 in the region of within 7.4 Mbp centromeric to the Lmp2-hotspot, and two congeniclines with homozygous segment of r209/r209 in the region of within 23 Mbp from the centromere. Our observation suggests that in addition to the MHC class II A there are four more MHC-linked type 1 diabetogenic genes in the 33.9 Mbp region centromeric to the Lmp2 gene, Idd1a, Idd1b, Idd1c and Idd1d. Our study aims to identify the four genes and examine their functions in the development of type 1 diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The 6th USA-Japan Meeting on Diabetes at Kyoto Medical Center, March 17-18, 2012
第六届美日糖尿病会议于 2012 年 3 月 17-18 日在京都医学中心举行
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Metallo-allixinate complexes with anti-diabetic and anti-metabolic syndrome activities.
具有抗糖尿病和抗代谢综合征活性的金属蒜氨酸复合物。
DOI:
--
发表时间:
2010
期刊:
Metallomics (The Royal Society of Chemistry)
影响因子:
--
作者:
[Sakurai H, Katoh A, Kiss T, Jakusch T, Hattori M.]
通讯作者:
Hattori M.
生活習慣病に対する新しい治療 DPP-IV阻害薬:2型糖尿病治療におけるインクレチン分解抑制の重要性
生活方式相关疾病新疗法DPP-IV抑制剂:抑制肠促胰素降解在治疗2型糖尿病中的重要性
DOI:
--
发表时间:
2010
期刊:
Journal of Integrated Medicine (JIM)
影响因子:
--
作者:
[服部正和, 知念良直, 中川嘉苗, 島津章, 桜井弘, William Sullivan]
通讯作者:
William Sullivan
生活習慣に対する新しい治療、DPP-IV阻害薬 : 2型糖尿病治療におけるインクレチン分解抑制の重要性
DPP-IV抑制剂,治疗生活习惯的新疗法:抑制肠促胰素降解在治疗2型糖尿病中的重要性
DOI:
--
发表时间:
2010
期刊:
Journal of Integrated Medicine (JIM).
影响因子:
--
作者:
[服部正和, 知念良直, 中川嘉苗, 島津章, 桜井弘, William Sullivan.]
通讯作者:
William Sullivan.
DOI:
10.1093/intimm/dxp127
发表时间:
2010-03-01
期刊:
INTERNATIONAL IMMUNOLOGY
影响因子:
4.4
作者:
[Brims, Daniel R., Qian, Jie, DiLorenzo, Teresa P.]
通讯作者:
DiLorenzo, Teresa P.
共 8 条
Study on the mechanism(s) of immunosenescence and its application for vaccine development.
-
批准号:26450443
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2014
-
负责人:HATTORI Masakazu
-
依托单位:
A new model mice for human chronic myelogenous leukemia by the disruption of SPA-1 gene.
-
批准号:15590337
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2003
-
负责人:HATTORI Masakazu
-
依托单位:
Regulation of T-cell and antigen-presenting cell interactions by Rapl.
-
批准号:12670300
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2000
-
负责人:HATTORI Masakazu
-
依托单位:
Essential role of transcriptional regulator Hesl in the early development of T cells.
-
批准号:10670300
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:1998
-
负责人:HATTORI Masakazu
-
依托单位:
Cell cycle regulation of a lympho-hematopoietic specific Rap1GTPase-activating protein, Spa-1 in lymphocyres.
-
批准号:07670367
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1995
-
负责人:HATTORI Masakazu
-
依托单位:
Analysis of a lympho-hematopoietic specific nuclear protein with homology to RaplGAP
-
批准号:05670300
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1993
-
负责人:HATTORI Masakazu
-
依托单位:
海外基金